Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]

Saved in:
Bibliographic Details
Main Authors: Moeber Mohammed Mahzari, Omar Buraykan Alluhayyan, Mahdi Hamad Almutairi, Mohammed Abdullah Bayounis, Yazeed Hasan Alrayani, Amir A. Omair, Awad Saad Alshahrani
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Journal of Clinical & Translational Endocrinology
Online Access:http://www.sciencedirect.com/science/article/pii/S2214623724000310
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850247189459107840
author Moeber Mohammed Mahzari
Omar Buraykan Alluhayyan
Mahdi Hamad Almutairi
Mohammed Abdullah Bayounis
Yazeed Hasan Alrayani
Amir A. Omair
Awad Saad Alshahrani
author_facet Moeber Mohammed Mahzari
Omar Buraykan Alluhayyan
Mahdi Hamad Almutairi
Mohammed Abdullah Bayounis
Yazeed Hasan Alrayani
Amir A. Omair
Awad Saad Alshahrani
author_sort Moeber Mohammed Mahzari
collection DOAJ
format Article
id doaj-art-e7af6e4140f944a6851f1b17405916ca
institution OA Journals
issn 2214-6237
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Journal of Clinical & Translational Endocrinology
spelling doaj-art-e7af6e4140f944a6851f1b17405916ca2025-08-20T01:59:00ZengElsevierJournal of Clinical & Translational Endocrinology2214-62372024-12-013810036010.1016/j.jcte.2024.100360Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]Moeber Mohammed Mahzari0Omar Buraykan Alluhayyan1Mahdi Hamad Almutairi2Mohammed Abdullah Bayounis3Yazeed Hasan Alrayani4Amir A. Omair5Awad Saad Alshahrani6College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; Department of Medicine, King Abdulaziz Medical City, Riyadh, Ministry of National Guard-Health Affairs, Riyadh 14611, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabia; Corresponding author at: King Saud bin Abdulaziz University for Health Sciences (www.ksau-hs.edu.sa), Mail Code 3130, P.O. Box 3660, Riyadh 11481, Saudi Arabia.Department of Medicine, King Abdulaziz Medical City, Riyadh, Ministry of National Guard-Health Affairs, Riyadh 14611, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi ArabiaCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi ArabiaCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi ArabiaCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi ArabiaCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi ArabiaCollege of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh 22490, Saudi Arabia; Department of Medicine, King Abdulaziz Medical City, Riyadh, Ministry of National Guard-Health Affairs, Riyadh 14611, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh 11481, Saudi Arabiahttp://www.sciencedirect.com/science/article/pii/S2214623724000310
spellingShingle Moeber Mohammed Mahzari
Omar Buraykan Alluhayyan
Mahdi Hamad Almutairi
Mohammed Abdullah Bayounis
Yazeed Hasan Alrayani
Amir A. Omair
Awad Saad Alshahrani
Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
Journal of Clinical & Translational Endocrinology
title Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
title_full Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
title_fullStr Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
title_full_unstemmed Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
title_short Corrigendum to “Safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post-transplant diabetes” [J. Clin. Translat. Endoc. 36C (2024) 100343]
title_sort corrigendum to safety and efficacy of semaglutide in post kidney transplants patients with type 2 diabetes or post transplant diabetes j clin translat endoc 36c 2024 100343
url http://www.sciencedirect.com/science/article/pii/S2214623724000310
work_keys_str_mv AT moebermohammedmahzari corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT omarburaykanalluhayyan corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT mahdihamadalmutairi corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT mohammedabdullahbayounis corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT yazeedhasanalrayani corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT amiraomair corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343
AT awadsaadalshahrani corrigendumtosafetyandefficacyofsemaglutideinpostkidneytransplantspatientswithtype2diabetesorposttransplantdiabetesjclintranslatendoc36c2024100343